AcuToken - ICO Details

HeadlineA decentralized ecosystem for movable assets
Starting date05/25/2018
Ending date06/10/2018
WebsiteView Website
WhitepaperView Whitepaper
Project Info

Two years ago we started Acudeen – a two-sided online marketplace where businesses can sell their invoices at a discounted price to a network of investors enabling them to receive funds ahead of time.

Last year, in 2017, we funded over $2.5M worth of invoices and had several strategic partnerships aside from our tech development milestones. In 2018, we decided to move onto blockchain and create from scratch a first of its kind supply chain and trade financing environment.

The AssetChain aim to be a unique decentralized ecosystem built around the existing platform. We want to allow businesses to sell other tangible and intangible assets while shaping the first asset registry based on blockchain for emerging markets.

We will be launching our “Initial Stellar Offering” or ICO based on Stellar exchange.

ICO Details
USA accepted
Currency AcceptedUSD,Others
Coin SymbolACU
Total Coins10,000,000,000
Coins for Sale2,147,483,647
Private-Sale/Pre-Mined Coins0
Coins Sold0%
Coin Price0.01 USD
Softcap Reached
Confirmed ExchangeStellar Decentralized Exchange, StellarTerm, StellarPort
Unsold Coins Goes to Investor
Stage Details
Start date05/25/2018
End date06/10/2018
Token for sale2,147,483,647
Token Price0.01 USD
Team Info
Core Team

Magellan Fetalino

Chief Executive Officer

Mario Salazar

Chief Technology Officer

Yacine Derradji

Chief Development Officer

Gregor Arn

Project Manager

Advisory Team

Simon Cocking

Sally Eaves

Nizam Ismail

Atty. Anthony Abad

Adeo Ressi

Please Login to join the discussion
Notify of
Share this ICO

Community Choice Winner

Featured ICOs
Invest like a Billionaire
A token backed by real beer!
Decentralized for Security, Centralized for Liquidity
Recently Viewed ICO

Moscow Blockchain
Join our Newsletter

Don't miss out!

Get discounts on ICOs & Blockchain products + Receive the latest News, Updates & PR from ICL.